Latest Period
Q4 2025
Security Snapshot
Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) Institutional Ownership
CUSIP: 171126204
13F Institutional Holders and Ownership History from Q3 2025 to Q1 2026
Institutions Reporting
15
Shares (Excl. Options)
899,359
Price
$31.00
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- PTHS on NYSE
- Shares outstanding
- 3,044,738
- Price per share
- $23.00
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 899,359
- Total reported value
- $27,880,129
- % of total 13F portfolios
- 0%
- Share change
- +436,597
- Value change
- +$13,536,994
- Number of holders
- 15
- Price from insider filings
- $23.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PTHS - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 171126204.
- 15 institutions reported positions in Q4 2025.
- 5 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 15 to 3 between Q4 2025 and Q1 2026.
- Reported value moved from $27,880,129 to $17,239.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 15 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 171126204?
CUSIP 171126204 identifies PTHS - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 171126204:
Significant Owners of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 50% | 0% | $145,296,959 | +$7,316,652 | 5,189,177 | +5.3% | Ligand Pharmaceuticals Incorporated | 06 Nov 2025 |
| 3i, LP | 9.9% | 0% | $8,673,699 | +$428,346 | 318,886 | +5.2% | 3i, LP | 31 Dec 2025 |
| Murchinson Ltd. | 9.1% | $7,840,000 | 280,000 | Murchinson Ltd. | 30 Sep 2025 | |||
| Ikarian Capital, LLC | 8.4% | +38% | $6,534,617 | +$1,771,892 | 255,758 | +37% | Ikarian Capital, LLC | 31 Dec 2025 |
| Friedberg Ezra M | 8.3% | 250,121 | Ezra Friedberg | 01 Jul 2025 |
As of 31 Dec 2025, 15 institutional investors reported holding 899,359 shares of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS). This represents 30% of the company’s total 3,044,738 outstanding shares.
Top 18 Institutional Shareholders
The largest institutional shareholders of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) together control 30% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Murchinson Ltd. | 9.5% | 289,479 | +3.4% | 5.6% | $8,973,849 |
| Ikarian Capital, LLC | 8.4% | 255,758 | +310% | 1% | $7,928,498 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.6% | 80,680 | +280% | 0.07% | $2,501,080 |
| J. Goldman & Co LP | 2.6% | 78,006 | 0.09% | $2,418,186 | |
| VANGUARD GROUP INC | 2.5% | 75,020 | +12% | 0% | $2,325,620 |
| CANTOR FITZGERALD, L. P. | 1.1% | 34,990 | 0.03% | $1,084,690 | |
| DIADEMA PARTNERS LP | 0.82% | 25,000 | +138% | 0.46% | $775,000 |
| Knott David M Jr | 0.63% | 19,281 | +215% | 0.28% | $597,711 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.45% | 13,625 | +32% | 0% | $422,375 |
| MILLENNIUM MANAGEMENT LLC | 0.36% | 11,057 | 0% | $342,767 | |
| Pale Fire Capital SE | 0.27% | 8,100 | 0.03% | $251,100 | |
| Persistent Asset Partners Ltd | 0.2% | 6,007 | +150% | 0.09% | $186,217 |
| Steward Partners Investment Advisory, LLC | 0.06% | 1,910 | 0% | 0% | $59,210 |
| UBS Group AG | 0.01% | 434 | +217% | 0% | $13,454 |
| BANK OF AMERICA CORP /DE/ | 0% | 12 | +9.1% | 0% | $372 |
| JPMORGAN CHASE & CO | 0% | 0 | -100% | $0 | |
| Tower Research Capital LLC (TRC) | 0% | 0 | -100% | $0 | |
| CITIGROUP INC | 0% | 0 | -100% | $0 |